These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 29054459
1. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis. Igari H, Ishikawa S, Nakazawa T, Oya Y, Futami H, Tsuyuzaki M, Suzuki K, Matsumura R. J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459 [Abstract] [Full Text] [Related]
2. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus. Tsuyuzaki M, Igari H, Okada N, Suzuki K. J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903 [Abstract] [Full Text] [Related]
4. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. Petruccioli E, Chiacchio T, Pepponi I, Vanini V, Urso R, Cuzzi G, Barcellini L, Cirillo DM, Palmieri F, Ippolito G, Goletti D. J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779 [Abstract] [Full Text] [Related]
5. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis. Petruccioli E, Vanini V, Chiacchio T, Cuzzi G, Cirillo DM, Palmieri F, Ippolito G, Goletti D. Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403 [Abstract] [Full Text] [Related]
6. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status. Tang J, Huang Y, Jiang S, Huang F, Ma T, Qi Y, Ma Y. Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942 [Abstract] [Full Text] [Related]
8. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes. Allen NP, Swarbrick G, Cansler M, Null M, Salim H, Miyamasu M, Howard J, Boyle J, Lewinsohn D, Lewinsohn D. Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508 [Abstract] [Full Text] [Related]
15. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment. Chiacchio T, Petruccioli E, Pepponi I, Vanini V, Gualano G, Cirillo D, Palmieri F, Ippolito G, Goletti D. Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513 [Abstract] [Full Text] [Related]
19. Evaluation of CD8+ response in QuantiFERON-TB Gold Plus as a marker of recent infection. Viana Machado F, Morais C, Santos S, Reis R. Respir Med; 2021 Dec; 185():106508. PubMed ID: 34171790 [Abstract] [Full Text] [Related]
20. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers. Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J, Aksamit TR, Escalante P. J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]